Skip to Content

Zytiga Sales Data

Rank 74 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Zytiga U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 74 (12) 11.86% 5.88%
Q3 2013 86 (2) 2.89%
Q2 2013 84 ()

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
February 17, 2017Low-Fat Meal May Boost Costly Cancer Drug
May 26, 2011New Drug Extends Survival for Men With Advanced Prostate Cancer
May 16, 2011New Drug Extends Life a Bit in Advanced Prostate Cancer
April 29, 2011Zytiga Approved for Advanced Prostate Cancer
Hide